Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$536M |
| 2 |
Apple
AAPL
|
+$362M |
| 3 |
Micron Technology
MU
|
+$270M |
| 4 |
Eli Lilly
LLY
|
+$228M |
| 5 |
Cisco
CSCO
|
+$179M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
Tesla
TSLA
|
+$463M |
| 3 |
NVIDIA
NVDA
|
+$424M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Meta Platforms (Facebook)
META
|
+$228M |
Sector Composition
| 1 | Technology | 19.7% |
| 2 | Healthcare | 16.66% |
| 3 | Consumer Discretionary | 13.03% |
| 4 | Industrials | 9.61% |
| 5 | Financials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ASM
2851
Avino Silver & Gold Mines
ASM
$640M
| $428K | ﹤0.01% |
388,957
-43,018
| -10% | -$47.3K |
|
2852
Mission Produce
AVO
$900M
| $427K | ﹤0.01% |
+33,300
| New | +$427K |
|
2853
NiSun International Enterprise Development Group
NISN
$16.9M
| $427K | ﹤0.01% |
26,668
-12,427
| -32% | -$199K |
|
2854
Crane NXT
CXT
$3.46B
| $426K | ﹤0.01% |
7,600
-43,900
| -85% | -$2.46M |
|
2855
Biglari Holdings Class B
BH
$943M
| $426K | ﹤0.01% |
2,476
+90
| +4% | +$15.5K |
|
|
SGMA
2856
DELISTED
Sigmatron International
SGMA
| $425K | ﹤0.01% |
149,087
+9,200
| +7% | +$26.2K |
|
|
ACCS
2857
ACCESS Newswire Inc.
ACCS
$40.3M
| $423K | ﹤0.01% |
35,438
-2,900
| -8% | -$34.7K |
|
2858
Sanara MedTech
SMTI
$302M
| $423K | ﹤0.01% |
14,000
-100
| -0.7% | -$3.02K |
|
2859
Chefs' Warehouse
CHEF
$2.7B
| $420K | ﹤0.01% |
10,000
-30,549
| -75% | -$1.28M |
|
2860
Minerva Neurosciences
NERV
$15.2M
| $420K | ﹤0.01% |
157,200
-10,500
| -6% | -$28K |
|
2861
Astria Therapeutics
ATXS
$419M
| $419K | ﹤0.01% |
38,061
+15,600
| +69% | +$172K |
|
2862
Alpha Teknova
TKNO
$238M
| $416K | ﹤0.01% |
+86,000
| New | +$416K |
|
2863
Vanguard Industrials ETF
VIS
$6.13B
| $416K | ﹤0.01% |
+1,600
| New | +$416K |
|
2864
Cheesecake Factory
CAKE
$2.82B
| $415K | ﹤0.01% |
+10,245
| New | +$415K |
|
2865
Compass Therapeutics
CMPX
$613M
| $410K | ﹤0.01% |
222,600
+82,000
| +58% | +$151K |
|
2866
CVD Equipment Corp
CVV
$21.1M
| $409K | ﹤0.01% |
123,682
-4,600
| -4% | -$15.2K |
|
2867
iShares ESG Aware MSCI EM ETF
ESGE
$5.34B
| $408K | ﹤0.01% |
+11,200
| New | +$408K |
|
2868
Smart Sand
SND
$75.1M
| $408K | ﹤0.01% |
206,900
-63,900
| -24% | -$126K |
|
2869
Prelude Therapeutics
PRLD
$64M
| $408K | ﹤0.01% |
196,900
-9,700
| -5% | -$20.1K |
|
|
LITB
2870
LightInTheBox
LITB
$38M
| $407K | ﹤0.01% |
140,933
-2,822
| -2% | -$8.16K |
|
|
LUNA
2871
DELISTED
Luna Innovations Incorporated
LUNA
| $407K | ﹤0.01% |
+173,300
| New | +$407K |
|
2872
Pro-Dex
PDEX
$108M
| $407K | ﹤0.01% |
13,640
+1,400
| +11% | +$41.8K |
|
2873
First Trust Energy AlphaDEX Fund
FXN
$281M
| $407K | ﹤0.01% |
+25,100
| New | +$407K |
|
2874
Arbor Realty Trust
ABR
$2.25B
| $407K | ﹤0.01% |
+26,140
| New | +$407K |
|
2875
Quince Therapeutics
QNCX
$85.9M
| $406K | ﹤0.01% |
522,576
+38,674
| +8% | +$30K |
|